Annual EBITDA
-$326.98 M
-$196.55 M-150.71%
December 31, 2024
Summary
- As of March 10, 2025, IDYA annual EBITDA is -$326.98 million, with the most recent change of -$196.55 million (-150.71%) on December 31, 2024.
- During the last 3 years, IDYA annual EBITDA has fallen by -$279.74 million (-592.22%).
- IDYA annual EBITDA is now -2227.72% below its all-time high of -$14.05 million, reached on December 31, 2017.
Performance
IDYA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$144.14 M
-$78.26 M-118.79%
December 31, 2024
Summary
- As of March 10, 2025, IDYA quarterly EBITDA is -$144.14 million, with the most recent change of -$78.26 million (-118.79%) on December 31, 2024.
- Over the past year, IDYA quarterly EBITDA has dropped by -$94.20 million (-188.65%).
- IDYA quarterly EBITDA is now -9193.88% below its all-time high of $1.58 million, reached on September 30, 2022.
Performance
IDYA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$323.78 M
-$103.25 M-46.81%
December 31, 2024
Summary
- As of March 10, 2025, IDYA TTM EBITDA is -$323.78 million, with the most recent change of -$103.25 million (-46.81%) on December 31, 2024.
- Over the past year, IDYA TTM EBITDA has dropped by -$168.75 million (-108.84%).
- IDYA TTM EBITDA is now -5393.45% below its all-time high of -$5.89 million, reached on March 31, 2018.
Performance
IDYA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IDYA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -150.7% | -188.7% | -108.8% |
| 3 y3 years | -592.2% | -188.7% | -108.8% |
| 5 y5 years | -660.0% | -188.7% | -108.8% |
IDYA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -592.2% | at low | -9193.9% | at low | -585.5% | at low |
| 5 y | 5-year | -862.7% | at low | -9193.9% | at low | -1044.7% | at low |
| alltime | all time | -2227.7% | at low | -9193.9% | at low | -5393.4% | at low |
IDEAYA Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$326.98 M(+150.7%) | -$144.14 M(+118.8%) | -$323.78 M(+46.8%) |
| Sep 2024 | - | -$65.88 M(+3.2%) | -$220.54 M(+17.8%) |
| Jun 2024 | - | -$63.83 M(+27.8%) | -$187.16 M(+20.7%) |
| Mar 2024 | - | -$49.94 M(+22.1%) | -$155.04 M(+18.9%) |
| Dec 2023 | -$130.42 M(+121.1%) | -$40.89 M(+25.8%) | -$130.42 M(+13.4%) |
| Sep 2023 | - | -$32.50 M(+2.5%) | -$115.05 M(+42.1%) |
| Jun 2023 | - | -$31.71 M(+25.2%) | -$80.97 M(+14.2%) |
| Mar 2023 | - | -$25.32 M(-0.8%) | -$70.89 M(+20.2%) |
| Dec 2022 | -$58.99 M(+24.9%) | -$25.52 M(-1710.2%) | -$58.99 M(+15.5%) |
| Sep 2022 | - | $1.58 M(-107.3%) | -$51.05 M(-19.7%) |
| Jun 2022 | - | -$21.64 M(+61.3%) | -$63.57 M(+22.5%) |
| Mar 2022 | - | -$13.41 M(-23.7%) | -$51.90 M(+9.9%) |
| Dec 2021 | -$47.24 M | -$17.59 M(+60.8%) | -$47.24 M(+36.6%) |
| Sep 2021 | - | -$10.93 M(+9.7%) | -$34.57 M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$9.96 M(+13.8%) | -$28.29 M(-7.5%) |
| Mar 2021 | - | -$8.75 M(+77.9%) | -$30.57 M(-10.0%) |
| Dec 2020 | -$33.96 M(-21.1%) | -$4.92 M(+5.8%) | -$33.96 M(-15.2%) |
| Sep 2020 | - | -$4.65 M(-62.1%) | -$40.03 M(-14.2%) |
| Jun 2020 | - | -$12.25 M(+0.9%) | -$46.68 M(+2.9%) |
| Mar 2020 | - | -$12.14 M(+10.5%) | -$45.37 M(+5.4%) |
| Dec 2019 | -$43.03 M(+21.1%) | -$10.99 M(-2.7%) | -$43.03 M(+5.2%) |
| Sep 2019 | - | -$11.30 M(+3.3%) | -$40.91 M(-4.9%) |
| Jun 2019 | - | -$10.94 M(+11.6%) | -$43.01 M(+9.1%) |
| Mar 2019 | - | -$9.80 M(+10.5%) | -$39.44 M(+11.0%) |
| Dec 2018 | -$35.53 M(+152.9%) | -$8.87 M(-33.8%) | -$35.53 M(+33.3%) |
| Sep 2018 | - | -$13.40 M(+82.0%) | -$26.66 M(+101.1%) |
| Jun 2018 | - | -$7.36 M(+24.9%) | -$13.26 M(+124.9%) |
| Mar 2018 | - | -$5.89 M | -$5.89 M |
| Dec 2017 | -$14.05 M | - | - |
FAQ
- What is IDEAYA Biosciences annual EBITDA?
- What is the all time high annual EBITDA for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual EBITDA year-on-year change?
- What is IDEAYA Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly EBITDA year-on-year change?
- What is IDEAYA Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for IDEAYA Biosciences?
- What is IDEAYA Biosciences TTM EBITDA year-on-year change?
What is IDEAYA Biosciences annual EBITDA?
The current annual EBITDA of IDYA is -$326.98 M
What is the all time high annual EBITDA for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual EBITDA is -$14.05 M
What is IDEAYA Biosciences annual EBITDA year-on-year change?
Over the past year, IDYA annual EBITDA has changed by -$196.55 M (-150.71%)
What is IDEAYA Biosciences quarterly EBITDA?
The current quarterly EBITDA of IDYA is -$144.14 M
What is the all time high quarterly EBITDA for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly EBITDA is $1.58 M
What is IDEAYA Biosciences quarterly EBITDA year-on-year change?
Over the past year, IDYA quarterly EBITDA has changed by -$94.20 M (-188.65%)
What is IDEAYA Biosciences TTM EBITDA?
The current TTM EBITDA of IDYA is -$323.78 M
What is the all time high TTM EBITDA for IDEAYA Biosciences?
IDEAYA Biosciences all-time high TTM EBITDA is -$5.89 M
What is IDEAYA Biosciences TTM EBITDA year-on-year change?
Over the past year, IDYA TTM EBITDA has changed by -$168.75 M (-108.84%)